Clearmind Medicine Inc.
CMND · NASDAQ
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,255 | -$6,234 | -$6,895 | -$2,725 |
| Dep. & Amort. | $51 | $42 | $83 | $3 |
| Deferred Tax | $104 | $17 | $41 | $0 |
| Stock-Based Comp. | $884 | $366 | $2 | $620 |
| Change in WC | -$130 | -$704 | $1,688 | $26 |
| Other Non-Cash | -$513 | $211 | -$2 | -$758 |
| Operating Cash Flow | -$4,859 | -$6,301 | -$5,084 | -$2,835 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$0 | -$231 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$350 | $0 | $0 | -$20 |
| Inv. Sales/Matur. | $79 | $0 | $0 | $0 |
| Other Inv. Act. | $34 | -$26 | -$8 | $0 |
| Investing Cash Flow | -$238 | -$26 | -$8 | -$251 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$43 | -$41 | -$0 | $0 |
| Stock Issued | $2,192 | $8,037 | $428 | $4,349 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,105 | $3,668 | $116 | $3,007 |
| Financing Cash Flow | $6,254 | $11,664 | $698 | $7,356 |
| Forex Effect | -$12 | -$38 | -$31 | $20 |
| Net Chg. in Cash | $1,146 | $5,299 | -$4,424 | $4,290 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,428 | $129 | $4,599 | $330 |
| End Cash | $6,574 | $5,428 | $176 | $4,619 |
| Free Cash Flow | -$4,859 | -$6,301 | -$5,091 | -$3,066 |